Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.
Saved in:
| Title: | Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells. |
|---|---|
| Authors: | Heinemann L; Medical Department A, University Hospital Münster, Münster, Germany., Möllers KM; Medical Department A, University Hospital Münster, Münster, Germany., Ahmed HMM; Medical Department A, University Hospital Münster, Münster, Germany., Wei L; Institute of Medical Informatics, University of Münster, Münster, Germany., Sun K; Medical Department A, University Hospital Münster, Münster, Germany., Nimmagadda SC; Medical Department A, University Hospital Münster, Münster, Germany., Frank D; Medical Department A, University Hospital Münster, Münster, Germany., Baumann A; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Poos AM; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Dugas M; Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany., Varghese J; Institute of Medical Informatics, University of Münster, Münster, Germany., Raab MS; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Khandanpour C; Medical Department A, University Hospital Münster, Münster, Germany.; Department of Haematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Jun 20; Vol. 12, pp. 874325. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.874325 |
